1. Skuta GL e col “Intraoperative mitomycine versus postoperative 5 FU in high risk glaucoma filtering surgery” Ophthalmology 1992; 99: 438-444
  2. European Glaucoma Society “Terminology and Guidelines for Glaucoma” 3rd Edition. Savona, Italy: Editrice Dogma 2008
  3. Tsai JC, Feuer WJ, Parrish RK 2nd, Grajewski AL “5 FU filtering surgery and Neovascular glaucoma. Long term follow-up of the original pilot study” Ophtahlmol 1995; 102: 887-892; discussion 8883-892.
  4. Five year follow-up of the Fluorouracil Filtering Surgery Study. The Fluorouracil Filtering Surgery Study Group” Am J Ophthalmol 1996; 121: 349-366
  5. Mandal AK, Bagga H, Nutheti R, Gothwal VK, Nanda AK “Trabeculectomy with or without MMC for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery”Eye 2003; 17: 53-62
  6. Stravou P, Murray PI, “Long term follow-up of trabeculectomy without antimetabolites in patients with uveitis” Am J Ophthalmol 1999; 128: 434-439
  7. Broadway D, Grierson I, Hitchings R “Racial differences in the results of glaucoma filtration surgery: are racial differences in the conjunctival cell profile important?” Br J Ophthalmol 1994; 78(3): 457-472
  8. Sturmer J, Broadway DC, Hitchings RA “Young patient trabeculectomy. Assessment of risk factors for failure” Ophthalmol 1993; 100: 928-939
  9. Khaw PT, Chang L Wong TT e col “Modulation of wound healing after glaucoma surgery” Curr Opin Ophthalmol 2001; 12(2): 143-148
  10. Peng Tee Khaw, Peter Shah “Trabeculectomy” in Sharaawy T, Mermoud A “Atlas of glaucoma surgery” UK: Anshan; 2006 p.20--5
  11. Wells AP, Cordeiro MF, Bunce C, Khaw PT “Cystic bleb formation and related complications in limbus- versus fornix-based conjuntival flaps 284 in pediatric and young adult trabeculectomy with MMC” Ophthalmology 2003; 110: 2192-2197
  12. Wong J, Wang N, Miler JW, Schuman JS “Modulation of human fibroblast activity by selected angiogenesis inhibitors” Exp Eye Res 1994; 58(4): 439-451.
  13. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, Di Pietro LA “VEGF mediates angiogenic activity during the proliferative phase of wound healing” Am J Pathol 1998; 152(6): 1445-1452
  14. Wilgus TA, Ferreira AM, Oberyszyn TM, Bergdall VK, Di Pietro LA “Regulation of scar formation by VEGF” Lab Invest 2008; 88(6): 579-590
  15. Grewal DS, Jain R, Kumar H, Grewal SP “Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy: a pilot study” Ophthalmology 2008; 115(12): 2141-2145.
4ª Edição - Maio 2017